Global Lysosomal Storage Disease Treatment Market Research Report 2023

Report ID: 1891888 | Published Date: Oct 2024 | No. of Page: 84 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Enzyme Replacement Therapy
        1.2.3 Stem Cell Transplantation
        1.2.4 Substrate Reduction Therapy
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Lysosomal Storage Disease Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Stem Transplant Centers
        1.3.5 Research Organizations
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Lysosomal Storage Disease Treatment Market Perspective (2017-2028)
    2.2 Lysosomal Storage Disease Treatment Growth Trends by Region
        2.2.1 Lysosomal Storage Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Lysosomal Storage Disease Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Lysosomal Storage Disease Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Lysosomal Storage Disease Treatment Market Dynamics
        2.3.1 Lysosomal Storage Disease Treatment Industry Trends
        2.3.2 Lysosomal Storage Disease Treatment Market Drivers
        2.3.3 Lysosomal Storage Disease Treatment Market Challenges
        2.3.4 Lysosomal Storage Disease Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue
        3.1.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue (2017-2022)
        3.1.2 Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Lysosomal Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
    3.4 Global Lysosomal Storage Disease Treatment Market Concentration Ratio
        3.4.1 Global Lysosomal Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease Treatment Revenue in 2021
    3.5 Lysosomal Storage Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Lysosomal Storage Disease Treatment Product Solution and Service
    3.7 Date of Enter into Lysosomal Storage Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Lysosomal Storage Disease Treatment Breakdown Data by Type
    4.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2023-2028)
5 Lysosomal Storage Disease Treatment Breakdown Data by Application
    5.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Lysosomal Storage Disease Treatment Market Size (2017-2028)
    6.2 North America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    6.3 North America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Lysosomal Storage Disease Treatment Market Size (2017-2028)
    7.2 Europe Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    7.3 Europe Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Lysosomal Storage Disease Treatment Market Size (2017-2028)
    9.2 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    9.3 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Takeda
        11.1.1 Takeda Company Detail
        11.1.2 Takeda Business Overview
        11.1.3 Takeda Lysosomal Storage Disease Treatment Introduction
        11.1.4 Takeda Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.1.5 Takeda Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Lysosomal Storage Disease Treatment Introduction
        11.2.4 Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Detail
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Lysosomal Storage Disease Treatment Introduction
        11.3.4 Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.3.5 Sanofi Recent Development
    11.4 BioMarin
        11.4.1 BioMarin Company Detail
        11.4.2 BioMarin Business Overview
        11.4.3 BioMarin Lysosomal Storage Disease Treatment Introduction
        11.4.4 BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.4.5 BioMarin Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Lysosomal Storage Disease Treatment Introduction
        11.5.4 Merck Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Actelion Pharmaceuticals
        11.6.1 Actelion Pharmaceuticals Company Detail
        11.6.2 Actelion Pharmaceuticals Business Overview
        11.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Introduction
        11.6.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.6.5 Actelion Pharmaceuticals Recent Development
    11.7 Eli Lilly
        11.7.1 Eli Lilly Company Detail
        11.7.2 Eli Lilly Business Overview
        11.7.3 Eli Lilly Lysosomal Storage Disease Treatment Introduction
        11.7.4 Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
        11.7.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Enzyme Replacement Therapy
    Table 3. Key Players of Stem Cell Transplantation
    Table 4. Key Players of Substrate Reduction Therapy
    Table 5. Key Players of Others
    Table 6. Global Lysosomal Storage Disease Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Lysosomal Storage Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Lysosomal Storage Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Lysosomal Storage Disease Treatment Market Share by Region (2017-2022)
    Table 10. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Lysosomal Storage Disease Treatment Market Share by Region (2023-2028)
    Table 12. Lysosomal Storage Disease Treatment Market Trends
    Table 13. Lysosomal Storage Disease Treatment Market Drivers
    Table 14. Lysosomal Storage Disease Treatment Market Challenges
    Table 15. Lysosomal Storage Disease Treatment Market Restraints
    Table 16. Global Lysosomal Storage Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Lysosomal Storage Disease Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease Treatment as of 2021)
    Table 19. Ranking of Global Top Lysosomal Storage Disease Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Lysosomal Storage Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Lysosomal Storage Disease Treatment Product Solution and Service
    Table 23. Date of Enter into Lysosomal Storage Disease Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Lysosomal Storage Disease Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Lysosomal Storage Disease Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Takeda Company Detail
    Table 44. Takeda Business Overview
    Table 45. Takeda Lysosomal Storage Disease Treatment Product
    Table 46. Takeda Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 47. Takeda Recent Development
    Table 48. Pfizer Company Detail
    Table 49. Pfizer Business Overview
    Table 50. Pfizer Lysosomal Storage Disease Treatment Product
    Table 51. Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 52. Pfizer Recent Development
    Table 53. Sanofi Company Detail
    Table 54. Sanofi Business Overview
    Table 55. Sanofi Lysosomal Storage Disease Treatment Product
    Table 56. Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 57. Sanofi Recent Development
    Table 58. BioMarin Company Detail
    Table 59. BioMarin Business Overview
    Table 60. BioMarin Lysosomal Storage Disease Treatment Product
    Table 61. BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 62. BioMarin Recent Development
    Table 63. Merck Company Detail
    Table 64. Merck Business Overview
    Table 65. Merck Lysosomal Storage Disease Treatment Product
    Table 66. Merck Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 67. Merck Recent Development
    Table 68. Actelion Pharmaceuticals Company Detail
    Table 69. Actelion Pharmaceuticals Business Overview
    Table 70. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Product
    Table 71. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 72. Actelion Pharmaceuticals Recent Development
    Table 73. Eli Lilly Company Detail
    Table 74. Eli Lilly Business Overview
    Table 75. Eli Lilly Lysosomal Storage Disease Treatment Product
    Table 76. Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
    Table 77. Eli Lilly Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lysosomal Storage Disease Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Enzyme Replacement Therapy Features
    Figure 3. Stem Cell Transplantation Features
    Figure 4. Substrate Reduction Therapy Features
    Figure 5. Others Features
    Figure 6. Global Lysosomal Storage Disease Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Stem Transplant Centers Case Studies
    Figure 10. Research Organizations Case Studies
    Figure 11. Others Case Studies
    Figure 12. Lysosomal Storage Disease Treatment Report Years Considered
    Figure 13. Global Lysosomal Storage Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Lysosomal Storage Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Lysosomal Storage Disease Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Lysosomal Storage Disease Treatment Market Share by Players in 2021
    Figure 17. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease Treatment Revenue in 2021
    Figure 19. North America Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Lysosomal Storage Disease Treatment Market Share by Country (2017-2028)
    Figure 21. United States Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Lysosomal Storage Disease Treatment Market Share by Country (2017-2028)
    Figure 25. Germany Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Region (2017-2028)
    Figure 33. China Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Lysosomal Storage Disease Treatment Market Share by Country (2017-2028)
    Figure 41. Mexico Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Country (2017-2028)
    Figure 45. Turkey Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Takeda Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 49. Sanofi Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 50. BioMarin Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 52. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 53. Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
Pfizer
Sanofi
BioMarin
Merck
Actelion Pharmaceuticals
Eli Lilly
Frequently Asked Questions
Lysosomal Storage Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lysosomal Storage Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lysosomal Storage Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aesthetic Implants

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Arterial Cannulae

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More